Goal 3 Good health and well-being
Iconovo develops generic inhaler products that makes high-quality treatments available at a lower cost for people that have limited resources to spend on medicine. Furthermore, Iconovo aims to replace injections with inhaled products that will make it easier to distribute essential medicine in warm climate and avoiding hazardous waste like used needles.
We strive to improve maternal health according to Objective 3. 1 in our project with Monash University where we develop oxytocin in ICOone to reduce mortality during childbirth due to excessive bleeding. We also work with ISR to develop an inhaled COVID-19 vaccine that can be distributed at room temperature and given without syringes by healthcare workers.